Interleukin-3 inhibits cycloheximide of C-Jun mRNA in human monocytes: Possible role for a serine/threonine phosphatase

Cycloheximide is a strong inducer of the c‐jun protooncogene mRNA at concentrations (≤50 ng/ml) that do not inhibit protein synthesis in human monocytes. This induction is transient lasting 30–60 min in contrast to the sustained induction obtained with concentrations that inhibit protein synthesis. The pluripotent colony stimulating factor interleukin‐3 (IL‐3) (10 ng/ml) is also a modest inducer of the c‐jun gene in these cells; however, in combination with cycloheximide, IL‐3 dramatically reduces the c‐jun induction below levels induced by cycloheximide alone. This is a true inhibition and is not due to a change in temporal kinetics of induction because the suppression in the presence of IL‐3 is observed at both 30 and 60 min after simultaneous addition of both IL‐3 and cycloheximide. Preincubation of monocytes with 12.5 nM okadaic acid (a potent inhibitor of protein phosphatases 1 and 2A) and cycloheximide prior to addition of IL‐3 restored the level of c‐jun induction to that mediated by cycloheximide alone. This concentration of okadaic acid inhibited almost 70% of the phosphorylase phosphatase activity in monocyte lysates. These observations suggest that activation of protein serine/threonine phosphatase(s) underlies the ability of IL‐3 to inhibit cycloheximide induction of c‐jun in monocytes. © 1993 Wiley‐Liss, Inc.